Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment of Colistin Dependence-Developing Acinetobacter baumannii with Antibiotic Combinations at Subinhibitory Concentrations.

Microbial drug resistance (Larchmont, N.Y.) - 1 Oct 2023

Jo Jeongwoo, Lee Ji Young, Cho Hongbaek, Ko Kwan Soo

Abstract excerpt

Recent studies have revealed that colistin dependence frequently develops in colistin-susceptible Acinetobacter baumannii isolates. Despite resistance in parental strains, colistin-dependent mutants showed increased susceptibility to several antibiotics, which suggests the possibility of developing strategies to eliminate multidrug-resistant (MDR) A. baumannii. We investigated in vitro and in vivo efficacy of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acinetobacter baumannii
Share to Acinetobacter Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amikacin

Share to Ceftriaxone

Share to Colistin

Share to Drug Resistance, Multiple, Bacterial

Share to Tetracycline

Source

Identifiers

PMID: 37379479
DOI: 10.1089/mdr.2022.0205

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment of Colistin Dependence-Developing Acinetobacter baumannii with Antibiotic Combinations at Subinhibitory Concentrations.PMID 37379479Read ↗

Enhancing colistin efficacy with combination therapies for multidrug-resistant P. aeruginosa and A. baumannii isolatesSemantic proximity Read ↗

In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.Semantic proximity Read ↗

Mutant prevention concentration of colistin alone and in combination with rifampicin for multidrug-resistant Acinetobacter baumannii.Semantic proximity Read ↗

Investigation of colistin heteroresistance in multidrug-resistant Acinetobacter baumannii clinical isolatesSemantic proximity Read ↗

<i>In vitro</i> and <i>in vivo</i> efficacy of the combination of colistin and endolysins against clinical strains of Multi-Drug Resistant (MDR) pathogensSemantic proximity Read ↗

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii.Semantic proximity Read ↗

Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance MechanismsSemantic proximity Read ↗

New Mutations Involved in Colistin Resistance in Acinetobacter baumannii.Semantic proximity Read ↗

Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.Semantic proximity Read ↗

Investigation of Colistin Heteroresistance and Some Factors Affecting Heteroresistance in Carbapenem-Resistant A. baumannii StrainsSemantic proximity Read ↗

Combating Multidrug Resistance in Escherichia coli and Klebsiella pneumoniae: A Synergistic Approach with Repurposed DrugsSemantic proximity Read ↗

Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coliSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.